title: What is the background incidence of malignancy in children with rheumatic disease?
abstract: Until recently, relatively little was known about the background risk of malignancy in pediatric rheumatic diseases. Worrying reports about the development of malignancies in children treated with new biologic agents have prompted rigorous studies of the incidence of malignancy associated with juvenile idiopathic arthritis (JIA). These studies reveal that JIA is likely to be associated with an increased risk of incident malignancy, irrespective of treatment with new biologic agents. A preliminary study indicates that the background risk of malignancy is also elevated in pediatric-onset systemic lupus erythematosus. On the basis of simple observation, the background risk of malignancy among children with Sjögren syndrome and dermatomyositis seems much lower than the markedly elevated risk found in adults with the same diagnoses. Clearly, the background risk of malignancy must be considered in any evaluation of the safety of new therapeutic agents.
authors: Department of Pediatrics, Division of Rheumatology, The University of Alabama at Birmingham, Birmingham, AL 35233, USA. mmannion@peds.uab.edu
authors: Melissa L
authors: ML
authors: Mannion
authors: Timothy
authors: T
authors: Beukelman
mesh_terms: D000328:Adult; D001171:Arthritis, Juvenile / Q000150:complications; D002648:Child; D003882:Dermatomyositis / Q000150:complications; D006801:Humans; D015994:Incidence; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D009369:Neoplasms / Q000453:epidemiology* / Q000209:etiology; D012216:Rheumatic Diseases / Q000150:complications*; D012307:Risk Factors; D012859:Sjogren's Syndrome
references: Curr Rheumatol Rep. 2008 Apr;10(2):147-55
references: 18460271
references: Int J Cancer. 2000 Nov 1;88(3):497-502
references: 11054684
references: Arthritis Rheum. 2010 Aug;62(8):2183-4
references: 20506203
references: Arthritis Rheum. 2010 Dec;62(12):3776-82
references: 20827782
references: J Rheumatol. 2011 Apr;38(4):760-3
references: 21239753
references: Arthritis Care Res (Hoboken). 2012 Sep;64(9):1357-64
references: 22511558
references: Arthritis Rheum. 2006 Mar;54(3):692-701
references: 16508929
references: Arthritis Care Res (Hoboken). 2010 Jul;62(7):1024-8
references: 20506257
references: Cancer Causes Control. 2008 Oct;19(8):887-94
references: 18386139
references: Pediatr Rheumatol Online J. 2010 Aug 16;8:23
references: 20712883
references: Anticancer Res. 2012 Apr;32(4):1119-36
references: 22493341
references: Arthritis Rheum. 1983 Apr;26(4):572-3
references: 6838683
references: Arthritis Rheum. 2005 May;52(5):1481-90
references: 15880596
references: Rheum Dis Clin North Am. 2011 Nov;37(4):607-21
references: 22075200
references: Best Pract Res Clin Rheumatol. 2009 Aug;23(4):539-47
references: 19591783
references: Arthritis Care Res (Hoboken). 2010 Jun;62(6):800-4
references: 20535790
references: Arthritis Rheum. 2010 Aug;62(8):2517-24
references: 20506368
references: Pediatr Clin North Am. 2012 Apr;59(2):301-27
references: 22560572
references: Ann Rheum Dis. 2006 Jun;65(6):796-803
references: 16284097
references: J Rheumatol. 2005 Apr;32(4):744-6
references: 15801035
references: J Am Acad Dermatol. 1996 May;34(5 Pt 1):824-9
references: 8632081
references: Ann Rheum Dis. 2011 May;70(5):785-91
references: 21288960
references: J Rheumatol. 1993 Jul;20(7):1260-2
references: 8371239
references: Arch Intern Med. 2004 Jun 28;164(12):1275-84
references: 15226160
references: Am J Med. 2010 Dec;123(12):1150.e1-6
references: 21183006
references: J Korean Med Sci. 2009 Aug;24(4):715-21
references: 19654958
references: Arthritis Rheum. 2012 Apr;64(4):1263-71
references: 22328538
references: Arthritis Res Ther. 2008;10(2):R45
references: 18433475